サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1477141

前立腺生検市場：タイプ別、検査タイプ別、エンドユーザー別、国別、地域別-2024-2032年の産業分析、市場規模、市場シェア、予測

Prostate Biopsy Market, By Type, By Test Type, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 301 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.78円
前立腺生検市場：タイプ別、検査タイプ別、エンドユーザー別、国別、地域別-2024-2032年の産業分析、市場規模、市場シェア、予測
出版日: 2024年04月04日
発行: AnalystView Market Insights
ページ情報: 英文 301 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

前立腺生検市場規模は2023年に69億1,843万米ドルとなり、2024年から2032年にかけてCAGR 14.92％で拡大

前立腺生検市場-市場力学

前立腺がんの罹患率の増加が市場成長を促進する見込み

前立腺がんは、世界的に男性の間で流行しているがんであり、高齢化と診断技術の向上により、その診断は増加傾向にあります。前立腺がんの罹患率の増加により、前立腺生検などの診断処置の必要性が高まっています。PSA検査のようなスクリーニング検査を受ける人が増えるにつれて、異常が早期に発見されるようになり、生検によるさらなる診断評価の必要性につながっています。米国臨床腫瘍学会によると、前立腺がんは、皮膚がんを除いて男性に最も多いがんのひとつです。2023年には、米国で約288,300人の男性が前立腺がんの診断を受けると推定されています。世界全体では、2020年に約1,414,259人が前立腺がんと診断されました。さらに、画像技術の進歩と医療費の増加は、市場に成長機会をもたらしています。とはいえ、医療機器や診断手順に対する厳しい規制要件は、市場に課題をもたらす可能性があります。

前立腺生検市場-主要インサイト

調査アナリストの分析によると、世界市場は予測期間（2024-2032年）に約14.92%のCAGRで毎年成長すると予測されます。

タイプ別セグメンテーションでは、前立腺針生検が2023年に最大市場シェアを示すと予測されています。

検査タイプ別では、2023年にはバイオマーカー検査が主要タイプに

地域別では、北米が2023年に収益を上げる主要市場です。

前立腺生検市場-セグメンテーション分析：

世界の前立腺生検市場は、タイプ、検査タイプ、エンドユーザー、地域に基づいてセグメント化されます。

市場はタイプによって2つに区分される：前立腺針生検と前立腺液状生検です。前立腺針生検が市場の大半のシェアを占めています。前立腺生検市場、特に前立腺針生検に特化した分野は、技術の進歩、低侵襲技術への関心の高まり、前立腺がん検診への意識の高まりにより、一貫した成長を遂げています。

市場は検査タイプによって3つのカテゴリーに区分される：すなわち、免疫組織化学、生検、バイオマーカー検査、画像検査、その他です。バイオマーカー検査は市場をリードするカテゴリーです。これらの検査は前立腺生検市場において不可欠なものとなっており、より良いリスク評価を提供し、生検の選択を支援し、前立腺がん患者に合わせた治療選択肢を提供します。

市場はエンドユーザーによって3つのカテゴリーに区分される：がん研究機関、診断研究所、病院、その他の事業体。エンドユーザーの各セグメントは、前立腺がんの診断、治療、研究に独自の貢献をしています。

前立腺生検市場-地理的洞察

この市場は、北米、ラテンアメリカ、欧州、アジア太平洋、中東アフリカに地理的に広がっています。これらの地域は、事業活動を行っている国によってさらに区分されます。北米地域は、高度な生検装置の存在と継続的な技術進歩により市場を独占しています。北米は確立されたヘルスケアインフラと強力な医療機器産業の恩恵を受けています。先進医療技術協会によると、米国は世界の医療技術市場の40％以上を占め、最大のシェアを占めています。また、北米は医療研究、技術革新、技術開発の中心地としての役割を果たしています。さらに、欧州は市場成長において2番目に大きな地域を占めているが、これは主に国民の病気に対する意識が高いためです。

前立腺生検市場-競合情勢：

前立腺生検市場の競合情勢では、生検装置や器具の開発・製造に注力する企業が、生検の精度、安全性、患者の幸福を高める革新的技術をもたらそうと激しい競争を繰り広げています。同様に、分子診断やバイオマーカー検査に特化した企業は、従来の生検法を補完する検査を提供し、前立腺がんの攻撃性や治療への反応についてさらなる洞察を提供しています。自社製品を差別化し、強固なパートナーシップを築き、臨床的有効性を示すことができる企業は、この厳しい環境下で成功を収めることができます。

目次

第1章 前立腺生検市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 前立腺生検の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 前立腺生検産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 前立腺生検市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 前立腺生検市場情勢

  • 前立腺生検市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 前立腺生検市場- タイプ別

  • 概要
    • タイプ別セグメントシェア分析
    • 前立腺針生検
    • 前立腺液体生検

第8章 前立腺生検市場- 検査タイプ別

  • 概要
    • 検査タイプ別セグメントシェア分析
    • 免疫組織化学
    • 生検
    • バイオマーカー検査
    • 画像検査
    • その他

第9章 前立腺生検市場- エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • がん調査機関
    • 診断検査室
    • 病院
    • その他

第10章 前立腺生検市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- 前立腺生検業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Thermo Fisher Scientific Inc.
    • CR Bard Inc.
    • STERIS LAB Srl
    • Boston Scientific Corporation
    • Cook
    • BIOBOT SURGICAL PTE LTD
    • 3D Biopsy Inc.
    • Eigen
    • Koninklijke Philips NV
    • Guardant Health Inc.
    • PURE Medical Device SA
    • Dickinson and Co.
    • F. Hoffmann-La Roche Ltd.
    • SOMATEX Medical Technologies GmbH
    • Others

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Prostate Biopsy Market: Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Prostate Biopsy Market, by Type 2019-2032 (USD Million)
  • TABLE Prostate Biopsy Market: Test Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Test Type
  • TABLE Global Prostate Biopsy Market, by Test Type 2019-2032 (USD Million)
  • TABLE Prostate Biopsy Market: End-User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Prostate Biopsy Market, by End-User 2019-2032 (USD Million)
  • TABLE Prostate Biopsy Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Prostate Biopsy Market, by Region 2019-2032 (USD Million)
  • TABLE North America Prostate Biopsy Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Prostate Biopsy Market, by Type, 2019-2032 (USD Million)
  • TABLE North America Prostate Biopsy Market, by Test Type, 2019-2032 (USD Million)
  • TABLE North America Prostate Biopsy Market, by End-User, 2019-2032 (USD Million)
  • TABLE Europe Prostate Biopsy Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Prostate Biopsy Market, by Type, 2019-2032 (USD Million)
  • TABLE Europe Prostate Biopsy Market, by Test Type, 2019-2032 (USD Million)
  • TABLE Europe Prostate Biopsy Market, by End-User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Prostate Biopsy Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Prostate Biopsy Market, by Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Prostate Biopsy Market, by Test Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Prostate Biopsy Market, by End-User, 2019-2032 (USD Million)
  • TABLE Latin America Prostate Biopsy Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Prostate Biopsy Market, by Type, 2019-2032 (USD Million)
  • TABLE Latin America Prostate Biopsy Market, by Test Type, 2019-2032 (USD Million)
  • TABLE Latin America Prostate Biopsy Market, by End-User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Prostate Biopsy Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Prostate Biopsy Market, by Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Prostate Biopsy Market, by Test Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Prostate Biopsy Market, by End-User, 2019-2032 (USD Million)
目次
Product Code: ANV2538

REPORT HIGHLIGHT

Prostate Biopsy Market size was valued at USD 6,918.43 million in 2023, expanding at a CAGR of 14.92% from 2024 to 2032.

A prostate biopsy involves the extraction of small tissue samples from the prostate gland by a doctor to conduct cancer testing. This form of cancer is highly prevalent, with an estimated 174,000 men expected to receive a diagnosis this year, and approximately 31,000 of them succumbing to the disease. However, for the majority of men, prostate cancer either poses no issues or can be easily treated. It is important to note that a definitive diagnosis of prostate cancer cannot be made without undergoing a biopsy. Typically, a prostate biopsy is recommended if abnormalities are detected during routine screening tests, such as elevated levels of prostate-specific antigen (PSA) in the blood or abnormal findings during a digital rectal examination (DRE).

Prostate Biopsy Market- Market Dynamics

The growing incidence of prostate cancer is expected to propel the market growth

Prostate cancer is a prevalent cancer among men globally, with its diagnosis on the rise due to aging populations and improved diagnostic techniques. The increasing incidence of prostate cancer has led to a greater need for diagnostic procedures such as prostate biopsies. As more individuals undergo screening tests like PSA testing, abnormalities are identified earlier, leading to the necessity for further diagnostic assessments through biopsies. According to the American Society of Clinical Oncology, prostate cancer is among most common cancer in men, excluding skin cancer. It is estimated that in 2023, around 288,300 men in the United States will receive a prostate cancer diagnosis. Globally, approximately 1,414,259 individuals were diagnosed with prostate cancer in 2020. Moreover, advancements in imaging technologies and rising healthcare expenditure present growth opportunities for the market. Nevertheless, stringent regulatory requirements for medical devices and diagnostic procedures may present challenges for the market.

Prostate Biopsy Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 14.92% over the forecast period (2024-2032)

Based on Type segmentation, Prostate Needle Biopsy was predicted to show maximum market share in the year 2023

Based on Test Type segmentation, Biomarker Tests were the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Prostate Biopsy Market- Segmentation Analysis:

The Global Prostate Biopsy Market is segmented based on Type, Test Type, End-User, and Region.

The market is segmented into two categories according to Type: Prostate Needle Biopsy and Prostate Liquid Biopsy. Prostate Needle Biopsy holds the majority share in the market. The market for prostate biopsies, specifically the sector dedicated to prostate needle biopsies, is experiencing consistent growth due to technological progress, rising interest in minimally invasive techniques, and heightened awareness of prostate cancer screening.

The market is segmented into three categories according to Test Type: Immunohistochemistry, Biopsy, Biomarker Tests, Imaging Tests, and Others. Biomarker Tests are the leading category in the market. These tests have become essential in the prostate biopsy market, providing better risk assessment, assisting in biopsy choices, and facilitating tailored treatment options for prostate cancer patients.

The market is segmented into three categories according to End-User: Cancer Research Institutes, Diagnostic Laboratories, Hospitals, and other entities. Each segment of end-users contributes uniquely to the diagnosis, treatment, and study of prostate cancer.

Prostate Biopsy Market- Geographical Insights

This market is geographically widespread across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided based on the countries involved in business activities. The North American region dominates the market due to the presence of advanced biopsy devices and continuous technological advancements. North America benefits from a well-established healthcare infrastructure and a strong medical device industry. According to the Advanced Medical Technology Association, the United States holds the largest share of the global medtech market, accounting for over 40% of it. Additionally, North America serves as a center for medical research, innovation, and technological development. Furthermore, Europe holds the second-largest region for market growth, primarily due to the high level of disease awareness among the population.

Prostate Biopsy Market- Competitive Landscape:

In the competitive landscape of the Prostate Biopsy Market, companies focused on developing and producing biopsy devices and instruments are in intense competition to bring forth innovative technologies that enhance biopsy precision, safety, and patient well-being. Similarly, companies specializing in molecular diagnostics and biomarker testing are providing tests that supplement conventional biopsy methods, offering further insights into the aggressiveness of prostate cancer and the response to treatment. Those companies that can distinguish their products, forge robust partnerships, and showcase clinical effectiveness are well-positioned to thrive in this challenging environment.

Recent Developments:

Thermo Fisher Scientific has recently unveiled more than 50 novel Absolute Q Liquid Biopsy Assays that can be utilized on the Applied Biosystems QuantStudio Absolute Q dPCR System*. This advanced digital PCR (dPCR) system is fully integrated and has been specifically designed to deliver remarkably precise and consistent results in just 90 minutes, requiring minimal manual intervention.

In an exciting development, Thermo Fisher Scientific has also announced a collaboration with Bayer to develop companion diagnostic assays for the drugmaker's cutting-edge precision cancer therapies.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PROSTATE BIOPSY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Thermo Fisher Scientific Inc.

C. R. Bard Inc.

STERIS LAB S.r.l

Boston Scientific Corporation

Cook

BIOBOT SURGICAL PTE LTD

3D Biopsy Inc.

Eigen

Koninklijke Philips N.V.

Guardant Health Inc.

PURE Medical Device SA

Dickinson and Co.

F. Hoffmann-La Roche Ltd.

SOMATEX Medical Technologies GmbH

Others

GLOBAL PROSTATE BIOPSY MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Prostate Needle Biopsy
  • Prostate Liquid Biopsy

GLOBAL PROSTATE BIOPSY MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Immunohistochemistry
  • Biopsy
  • Biomarker Tests
  • Imaging Tests
  • Others

GLOBAL PROSTATE BIOPSY MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Cancer Research Institutes
  • Diagnostic Laboratories
  • Hospitals
  • Others

GLOBAL PROSTATE BIOPSY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Prostate Biopsy Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Prostate Biopsy Market Snippet by Type
    • 2.1.2.Prostate Biopsy Market Snippet by Test Type
    • 2.1.3.Prostate Biopsy Market Snippet by End-User
    • 2.1.4.Prostate Biopsy Market Snippet by Country
    • 2.1.5.Prostate Biopsy Market Snippet by Region
  • 2.2.Competitive Insights

3.Prostate Biopsy Key Market Trends

  • 3.1.Prostate Biopsy Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Prostate Biopsy Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Prostate Biopsy Market Opportunities
  • 3.4.Prostate Biopsy Market Future Trends

4.Prostate Biopsy Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Prostate Biopsy Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Prostate Biopsy Market Landscape

  • 6.1.Prostate Biopsy Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Prostate Biopsy Market - By Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2.Prostate Needle Biopsy
    • 7.1.3.Prostate Liquid Biopsy

8.Prostate Biopsy Market - By Test Type

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Test Type, 2023 & 2032 (%)
    • 8.1.2.Immunohistochemistry
    • 8.1.3.Biopsy
    • 8.1.4.Biomarker Tests
    • 8.1.5.Imaging Tests
    • 8.1.6.Others

9.Prostate Biopsy Market - By End-User

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 9.1.2.Cancer Research Institutes
    • 9.1.3.Diagnostic Laboratories
    • 9.1.4.Hospitals
    • 9.1.5.Others

10.Prostate Biopsy Market- By Geography

  • 10.1.Introduction
    • 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2.North America
    • 10.2.1.Overview
    • 10.2.2.Prostate Biopsy Key Manufacturers in North America
    • 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4.North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5.North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.2.6.North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7.U.S.
      • 10.2.7.1.Overview
      • 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3.U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4.U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5.U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8.Canada
      • 10.2.8.1.Overview
      • 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3.Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4.Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5.Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3.Europe
    • 10.3.1.Overview
    • 10.3.2.Prostate Biopsy Key Manufacturers in Europe
    • 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4.Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5.Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.3.6.Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7.Germany
      • 10.3.7.1.Overview
      • 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3.Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4.Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5.Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8.Italy
      • 10.3.8.1.Overview
      • 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3.Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4.Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5.Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9.United Kingdom
      • 10.3.9.1.Overview
      • 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3.United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4.United Kingdom Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5.United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10.France
      • 10.3.10.1.Overview
      • 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3.France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4.France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5.France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11.Russia
      • 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2.Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3.Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4.Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12.Netherlands
      • 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2.Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3.Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4.Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13.Sweden
      • 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2.Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3.Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4.Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14.Poland
      • 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2.Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3.Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4.Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15.Rest of Europe
      • 10.3.15.1.Overview
      • 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3.Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4.Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.15.5.Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4.Asia Pacific (APAC)
    • 10.4.1.Overview
    • 10.4.2.Prostate Biopsy Key Manufacturers in Asia Pacific
    • 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4.Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5.Asia Pacific Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.4.6.Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7.India
      • 10.4.7.1.Overview
      • 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3.India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4.India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5.India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8.China
      • 10.4.8.1.Overview
      • 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3.China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4.China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5.China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9.Japan
      • 10.4.9.1.Overview
      • 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3.Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4.Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5.Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10.South Korea
      • 10.4.10.1.Overview
      • 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3.South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4.South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5.South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11.Australia
      • 10.4.11.1.Overview
      • 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3.Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4.Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5.Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12.Thailand
      • 10.4.12.1.Overview
      • 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3.Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4.Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5.Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13.Indonesia
      • 10.4.13.1.Overview
      • 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3.Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4.Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5.Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14.Philippines
      • 10.4.14.1.Overview
      • 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3.Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4.Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5.Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15.Rest of APAC
      • 10.4.15.1.Overview
      • 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3.Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4.Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5.Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5.Latin America
    • 10.5.1.Overview
    • 10.5.2.Prostate Biopsy Key Manufacturers in Latin America
    • 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4.Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5.Latin America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.5.6.Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7.Brazil
      • 10.5.7.1.Overview
      • 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3.Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4.Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5.Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8.Mexico
      • 10.5.8.1.Overview
      • 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3.Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4.Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5.Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9.Argentina
      • 10.5.9.1.Overview
      • 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3.Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4.Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5.Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10.Colombia
      • 10.5.10.1.Overview
      • 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3.Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4.Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5.Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11.Rest of LATAM
      • 10.5.11.1.Overview
      • 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3.Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4.Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5.Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6.Middle East and Africa
    • 10.6.1.Overview
    • 10.6.2.Prostate Biopsy Key Manufacturers in Middle East and Africa
    • 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4.Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5.Middle East and Africa Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.6.6.Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7.Saudi Arabia
      • 10.6.7.1.Overview
      • 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3.Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4.Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5.Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8.United Arab Emirates
      • 10.6.8.1.Overview
      • 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3.United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4.United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5.United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9.Israel
      • 10.6.9.1.Overview
      • 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3.Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4.Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5.Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10.Turkey
      • 10.6.10.1.Overview
      • 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3.Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4.Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5.Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11.Algeria
      • 10.6.11.1.Overview
      • 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3.Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4.Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5.Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12.Egypt
      • 10.6.12.1.Overview
      • 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3.Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4.Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5.Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13.Rest of MEA
      • 10.6.13.1.Overview
      • 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3.Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4.Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5.Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- Prostate Biopsy Industry

  • 11.1.Competitive Dashboard
  • 11.2.Company Profiles
    • 11.2.1.Thermo Fisher Scientific Inc.
    • 11.2.2.C. R. Bard Inc.
    • 11.2.3.STERIS LAB S.r.l
    • 11.2.4.Boston Scientific Corporation
    • 11.2.5.Cook
    • 11.2.6.BIOBOT SURGICAL PTE LTD
    • 11.2.7.3D Biopsy Inc.
    • 11.2.8.Eigen
    • 11.2.9.Koninklijke Philips N.V.
    • 11.2.10.Guardant Health Inc.
    • 11.2.11.PURE Medical Device SA
    • 11.2.12.Dickinson and Co.
    • 11.2.13.F. Hoffmann-La Roche Ltd.
    • 11.2.14.SOMATEX Medical Technologies GmbH
    • 11.2.15.Others

12.360 Degree Analyst View

13.Appendix

  • 13.1.Research Methodology
  • 13.2.References
  • 13.3.Abbreviations
  • 13.4.Disclaimer
  • 13.5.Contact Us